NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,742,000 | +13.9% | 36,093 | +4.2% | 0.00% | +33.3% |
| Q2 2022 | $2,408,000 | -16.3% | 34,639 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $2,876,000 | +171.6% | 34,715 | +146.1% | 0.00% | +200.0% |
| Q4 2021 | $1,059,000 | -34.8% | 14,104 | -0.3% | 0.00% | -50.0% |
| Q3 2021 | $1,624,000 | -47.8% | 14,152 | +0.9% | 0.00% | -50.0% |
| Q2 2021 | $3,112,000 | +68.1% | 14,029 | +0.2% | 0.00% | +33.3% |
| Q1 2021 | $1,851,000 | -61.8% | 14,000 | -50.0% | 0.00% | -25.0% |
| Q4 2020 | $4,844,000 | +210.5% | 27,988 | +99.7% | 0.00% | +33.3% |
| Q3 2020 | $1,560,000 | +87.7% | 14,012 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $831,000 | -12.0% | 14,012 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $944,000 | -20.1% | 14,012 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,181,000 | +12.7% | 14,012 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,048,000 | – | 14,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |